Corcept Therapeutics | CORT - Passivo Circulante





Passivo Circulante Alterar Data
Acadia Pharmaceuticals USD 305.52M 28.41M 2026-03
Alaunos Therapeutics USD 595K 218K 2026-03
ANI Pharmaceuticals USD 239.51M 38.6M 2026-03
Ardelyx USD 109.57M 20.96M 2026-03
Aurora Cannabis CAD 66.93M 79M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Canopy Growth CAD 158.44M 60.15M 2026-03
Corcept Therapeutics USD 153.8M 4.62M 2026-06
Eli Lilly USD 36.63B 1.41B 2026-03
J&J USD 54.9B 2.82B 2026-06
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Lexicon Pharmaceuticals USD 9.9M 10.97M 2026-03
Merck USD 26.94B 1.38B 2026-03
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Novartis USD 31.75B 374M 2026-06
Novartis USD 31.37B 4.1B 2026-03
Omeros USD 85.5M 2.28M 2025-06
Pacira USD 108.79M 11.8M 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Supernus Pharmaceuticals USD 373.93M 35.76M 2026-03
TG Therapeutics USD 187.11M 33.35M 2026-03